The stock of Exelixis Inc. (NASDAQ:EXEL) last traded at $19.33, down -2.23% from the previous session.
Data from the available sources indicates that Exelixis Inc. (NASDAQ:EXEL) is covered by 17 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $32.00 and a low of $17.00, we find $25.00. Given the previous closing price of $19.77, this indicates a potential upside of 26.45 percent. EXEL stock price is now 1.73% away from the 50-day moving average and 10.25% away from the 200-day moving average. The market capitalization of the company currently stands at $6.28B.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
In total, 1 analysts have assigned it a hold rating, and 14 have given it a buy rating. Brokers who have rated the stock have averaged $25.31 as their price target over the next twelve months.
.
In other news, Hessekiel Jeffrey, EVP, General Counsel & Sec sold 38,930 shares of the company’s stock on Apr 05. The stock was sold for $778,989 at an average price of $20.01. Upon completion of the transaction, the EVP, General Counsel & Sec now directly owns 582,435 shares in the company, valued at $11.26 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 10, Director WYSZOMIERSKI JACK L sold 15,300 shares of the business’s stock. A total of $254,133 was realized by selling the stock at an average price of $16.61. This leaves the insider owning 317,467 shares of the company worth $6.14 million. Insiders disposed of 942,210 shares of company stock worth roughly $18.21 million over the past 1 year. A total of 0.70% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in EXEL stock. A new stake in Exelixis Inc. shares was purchased by DEEP TRACK CAPITAL, LP during the first quarter worth $37,343,000. BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC invested $17,278,000 in shares of EXEL during the first quarter. In the first quarter, CALIGAN PARTNERS LP acquired a new stake in Exelixis Inc. valued at approximately $16,431,000. SOFINNOVA INVESTMENTS, INC. acquired a new stake in EXEL for approximately $16,068,000. TEKLA CAPITAL MANAGEMENT LLC purchased a new stake in EXEL valued at around $14,046,000 in the second quarter. In total, there are 548 active investors with 88.10% ownership of the company’s stock.
With an opening price of $19.76 on Tuesday morning, Exelixis Inc. (NASDAQ: EXEL) set off the trading day. During the past 12 months, Exelixis Inc. has had a low of $14.87 and a high of $22.47. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 5.00, and a quick ratio of 4.90. According to the stock market information, the enterprise value for the company is $5.18B, which is based on a 40.95 price-to-earnings ratio, a 1.51 price-to-earnings-growth ratio, and a beta of 0.67. The fifty day moving average price for EXEL is $19.05 and a two-hundred day moving average price translates $17.52 for the stock.
The latest earnings results from Exelixis Inc. (NASDAQ: EXEL) was released for Mar, 2023. According to the Biotechnology Company, earnings per share came in at $0.12, missing analysts’ expectations of $0.15 by -0.03. This compares to $0.21 EPS in the same period last year. The net profit margin was 9.20% and return on equity was 6.20% for EXEL. The company reported revenue of $408.79 million for the quarter, compared to $355.98 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 14.83 percent. For the current quarter, analysts expect EXEL to generate $445.15M in revenue.
